Búsqueda | Portal de Búsqueda de la BVS Colombia

1.

Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicenter, open-label phase-II trial.

Cramer, Paula; Tresckow, Julia V; Robrecht, Sandra; Bahlo, Jasmin; Fürstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J; Vehling-Kaiser, Ursula; Dürig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Böttcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael.

Haematologica ; 106(2): 543-554, 2021 02 01.

Artículo en Inglés | MEDLINE | ID: mdl-32107341

2.

T-LGLL: variety is the spice of this leukemia.

Pflug, Natali.

Blood ; 141(9): 967-969, 2023 03 02.

Artículo en Inglés | MEDLINE | ID: mdl-36862434

3.

Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML.

Holtick, Udo; Herling, Marco; Pflug, Natali; Chakupurakal, Geothy; Leitzke, Silke; Wolf, Dominik; Hallek, Michael; Scheid, Christof; Chemnitz, Jens M.

Ann Hematol ; 96(3): 479-487, 2017 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-27909887

4.

Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.

Pflug, Natali; Bahlo, Jasmin; Shanafelt, Tait D; Eichhorst, Barbara F; Bergmann, Manuela A; Elter, Thomas; Bauer, Kathrin; Malchau, Gebhart; Rabe, Kari G; Stilgenbauer, Stephan; Döhner, Hartmut; Jäger, Ulrich; Eckart, Michael J; Hopfinger, Georg; Busch, Raymonde; Fink, Anna-Maria; Wendtner, Clemens-Martin; Fischer, Kirsten; Kay, Neil E; Hallek, Michael.

Blood ; 124(1): 49-62, 2014 Jul 03.

Artículo en Inglés | MEDLINE | ID: mdl-24797299

5.

Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia.

Maurer, Christian; Pflug, Natali; Bahlo, Jasmin; Kluth, Sandra; Rhein, Christina; Cramer, Paula; Gross-Ophoff, Carolin; Langerbeins, Petra; Fink, Anna-Maria; Eichhorst, Barbara; Kreuzer, Karl-Anton; Fischer, Norbert; Tausch, Eugen; Stilgenbauer, Stephan; Böttcher, Sebastian; Döhner, Hartmut; Kneba, Michael; Dreyling, Martin; Binder, Mascha; Hallek, Michael; Wendtner, Clemens-Martin; Bergmann, Manuela; Fischer, Kirsten.

Eur J Haematol ; 97(3): 253-60, 2016 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-26643449

6.

Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG).

Cramer, Paula; Isfort, Susanne; Bahlo, Jasmin; Stilgenbauer, Stephan; Döhner, Hartmut; Bergmann, Manuela; Stauch, Martina; Kneba, Michael; Lange, Elisabeth; Langerbeins, Petra; Pflug, Natali; Kovacs, Gabor; Goede, Valentin; Fink, Anna-Maria; Elter, Thomas; Fischer, Kirsten; Wendtner, Clemens-Martin; Hallek, Michael; Eichhorst, Barbara.

Haematologica ; 100(11): 1451-9, 2015 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-26315931

7.

The CLL12 trial protocol: a placebo-controlled double-blind Phase III study of ibrutinib in the treatment of early-stage chronic lymphocytic leukemia patients with risk of early disease progression.

Langerbeins, Petra; Bahlo, Jasmin; Rhein, Christina; Cramer, Paula; Pflug, Natali; Fischer, Kirsten; Stilgenbauer, Stephan; Kreuzer, Karl Anton; Wendtner, Clemens-Martin; Eichhorst, Barbara; Hallek, Michael.

Future Oncol ; 11(13): 1895-903, 2015.

Artículo en Inglés | MEDLINE | ID: mdl-26161926

8.

Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.

Hopfinger, Georg; Busch, Raymonde; Pflug, Natali; Weit, Nicole; Westermann, Anne; Fink, Anna-Maria; Cramer, Paula; Reinart, Nina; Winkler, Dirk; Fingerle-Rowson, Günter; Stilgenbauer, Stephan; Döhner, Hartmut; Kandler, Gabriele; Eichhorst, Barbara; Hallek, Michael; Herling, Marco.

Cancer ; 119(12): 2258-67, 2013 Jun 15.

Artículo en Inglés | MEDLINE | ID: mdl-23512246

9.

Case Report: Large Granular Lymphocyte Leukemia (LGLL)-A Case Series of Challenging Presentations.

Pflug, Natali; Littauer, Annika; Beverungen, David; Sretenovic, Aleksandra; Wahnschaffe, Linus; Braun, Till; Dechow, Annika; Jungherz, Dennis; Otte, Moritz; Monecke, Astrid; Bach, Enrica; Franke, Georg-Nikolaus; Schwind, Sebastian; Jentzsch, Madlen; Platzbecker, Uwe; Herling, Marco; Vucinic, Vladan.

Front Oncol ; 11: 775313, 2021.

Artículo en Inglés | MEDLINE | ID: mdl-35070980

10.

Chronic lymphocytic leukemia.

Hallek, Michael; Pflug, Natali.

Ann Oncol ; 21 Suppl 7: vii154-64, 2010 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-20943609

11.

New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance.

Pflug, Natali; Cramer, Paula; Robrecht, Sandra; Bahlo, Jasmin; Westermann, Anne; Fink, Anna-Maria; Schrader, Alexandra; Mayer, Petra; Oberbeck, Sebastian; Seiler, Till; Zenz, Thorsten; Dürig, Jan; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Herling, Marco; Hopfinger, Georg.

Leuk Lymphoma ; 60(3): 649-657, 2019 03.

Artículo en Inglés | MEDLINE | ID: mdl-30234404

12.

Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study.

Herling, Marco; Dearden, Claire; Zaja, Francesco; El-Sharkawi, Dima; Ding, Wei; Bellido, Mar; Khot, Amit; Tick, Lidwine; Jacobsen, Eric; Eyre, Toby A; Roos-Weil, Damien; Kadia, Tapan; Lucchini, Elisa; Pflug, Natali; Davids, Matthew S; Pena, German; Mukherjee, Nabanita; Badawi, Mohamed; Vizkelety, Tamas; Staber, Philipp B.

Blood Adv ; 8(4): 842-845, 2024 Feb 27.

Artículo en Inglés | MEDLINE | ID: mdl-38190628

13.

Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective review.

Al-Sawaf, Othman; Cramer, Paula; Goede, Valentin; Hallek, Michael; Pflug, Natali.

Ther Adv Hematol ; 8(6): 197-205, 2017 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-28567239

14.

Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy.

Al-Sawaf, Othman; Fischer, Kirsten; Engelke, Anja; Pflug, Natali; Hallek, Michael; Goede, Valentin.

Drug Des Devel Ther ; 11: 295-304, 2017.

Artículo en Inglés | MEDLINE | ID: mdl-28182141

15.

Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use.

Lock, Dominik; Mockel-Tenbrinck, Nadine; Drechsel, Katharina; Barth, Carola; Mauer, Daniela; Schaser, Thomas; Kolbe, Carolin; Al Rawashdeh, Wael; Brauner, Janina; Hardt, Olaf; Pflug, Natali; Holtick, Udo; Borchmann, Peter; Assenmacher, Mario; Kaiser, Andrew.

Hum Gene Ther ; 28(10): 914-925, 2017 10.

Artículo en Inglés | MEDLINE | ID: mdl-28847167

16.

Obinutuzumab in Allogeneic Transplantation for CLL and Richter's Transformation in the Age of Targeted Therapies.

Pflug, Natali; Chakupurakal, Geothy; Fink, Anna-Maria; Robrecht, Sandra; Herling, Marco; Cramer, Paula; Holtick, Udo; Theurich, Sebastian; Schetelig, Johannes; Fischer, Kirsten; Ritgen, Matthias; Scheid, Christof; Eichhorst, Barbara; Dreger, Peter; Hallek, Michael; von Bergwelt-Baildon, Michael.

Hemasphere ; 5(12): e664, 2021 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-34881358

17.

Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota.

Pflug, Natali; Kluth, Sandra; Vehreschild, Jörg J; Bahlo, Jasmin; Tacke, Daniela; Biehl, Lena; Eichhorst, Barbara; Fischer, Kirsten; Cramer, Paula; Fink, Anna-Maria; von Bergwelt-Baildon, Michael; Stilgenbauer, Stephan; Hallek, Michael; Cornely, Oliver A; Vehreschild, Maria J G T.

Oncoimmunology ; 5(6): e1150399, 2016 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-27471619

18.

Second-line therapies of patients initially treated with fludarabine and cyclophosphamide or fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia within the CLL8 protocol of the German CLL Study Group.

Cramer, Paula; Fink, Anna-Maria; Busch, Raymonde; Eichhorst, Barbara; Wendtner, Clemens-Martin; Pflug, Natali; Langerbeins, Petra; Bahlo, Jasmin; Goede, Valentin; Schubert, Friederike; Döhner, Hartmut; Stilgenbauer, Stephan; Dreger, Peter; Kneba, Michael; Böttcher, Sebastian; Mayer, Jiri; Hallek, Michael; Fischer, Kirsten.

Leuk Lymphoma ; 54(8): 1821-2, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-23631654

19.

State of the art treatment of chronic lymphocytic leukaemia.